• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Treatment Intensification in Type 2 Diabetes: 3 Cases

Slideshow

When intensifying T2DM therapy to reach glycemic goals, newer agents target common comorbidities. Which would you choose in these 3 scenarios?

Choice of antihyperglycemic agent after metformin can now be selected to also address comorbidites often seen in T2DM patients. Each of the 3 patients in this short case quiz presents a challenge as well as an opportonity to optimize diabetes care.  

Related Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
New Study Shows Men with Diabetes Have Higher Risk of Disease-related Complications than Women

New Study Shows Men with Diabetes Have Higher Risk of Disease-related Complications than Women

May 17th 2024
Article

Men with diabetes had a greater risk of CVD, lower limb and kidney complications, and diabetic retinopathy compared to women with diabetes.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Cardiovascular-Kidney-Metabolic Syndrome in the US: Daily Dose / image credit: ©New Africa/AdobeStock

Cardiovascular-Kidney-Metabolic Syndrome in the US: Daily Dose

May 16th 2024
Article

Your daily dose of the clinical news you may have missed.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

FDA Reports More than 200 Injuries Related to Recalled Tandem Diabetes Insulin App / image credit tandem logo ©Rafael Henrique/stock.adobe.com

FDA Reports More than 200 Injuries Related to Recalled Tandem Diabetes Insulin App

May 9th 2024
Article

There have been 224 reported injuries as of April 15, 2024, the CDC said, but no reports of death related to the app intermittently crashing and rebooting.

Poor Cardiovascular-Kidney-Metabolic Health “Widespread” among US Adults, According to New Study

Poor Cardiovascular-Kidney-Metabolic Health “Widespread” among US Adults, According to New Study

May 8th 2024
Article

Results also showed that older adults, men, and Black adults face an increased risk of advanced stages of CKM syndrome.

© 2024 MJH Life Sciences

All rights reserved.